(BCSE™ NU A&NZ) helps evaluate global cognitive functioning in patients with dementia, mild ID, TBI, or suspected Alzheimer’s disease. This brief, reliable test is the stand-alone version of the BCSE NU A&NZ found in the WMS-5 A&NZ as an optional cognitive screener.
Brief Cognitive Status Exam | Normative Update – Australian and New Zealand
BCSE™ NU A&NZ
Brief Cognitive Status Exam, Normative Update – Australian and New Zealand(BCSE™ NU A&NZ) helps evaluate global cognitive functioning in patients with dementia, mild ID, TBI, or suspected Alzheimer’s disease. This brief, reliable test is the stand-alone version of the BCSE NU A&NZ found in the WMS-5 A&NZ as an optional cognitive screener.
BCSE Normative Update A&NZ Record Forms (Print)
A103000448342
Qualification Level
- Publication date:
- 2026
- Completion time:
- 15-20 minutes
- Administration:
- Paper-and-pencil, Q-interactive
- Age range:
- 16-90
- Qualification level:
- B
- Scoring options:
- Manual Scoring
Overview
This brief reliable screener is a stand-alone version of the Brief Cognitive Status Exam, Normative Update – Australian and New Zealand (BCSE™ NU A&NZ) found in the Wechsler Memory Scale®, Fifth Edition – Australian and New Zealand (WMS®-5 A&NZ)
The BCSE™ NU A&NZ helps clinicians to screen for cognitive challenges among a variety of individuals including those with dementia, mild ID, TBI, or suspected Alzheimer’s disease. BCSE covers the following domains:
- Orientation
- Time
- Mental Control
- Planning and Visual-Perceptual Processing
- Incidental Recall
- Inhibitory Control
- Verbal Productivity
Key Features
- Fast and Efficient: Complete the assessment in just 15-20 minutes
- Broad Age Range: Suitable for individuals aged 16 to 90
- Flexible Administration: Available in both paper format and Q-interactive®
- Clinically Relevant: Designed to identify below-average cognitive performance
- Co-developed with WMS®-5 A&NZ: Supports comprehensive evaluation alongside Wechsler Memory Scale®, Fifth Edition – Australian and New Zealand
Benefits
- Clinical Utility: Ideal for a wide range of professionals, including those working in psychiatric, medical, educational, and rehabilitation settings
- Updated Norms: Reflects current population data to ensure accurate assessment
- Brief yet Broad: Evaluate general cognitive status with a concise tool
- Easy to Interpret: Score classification focuses on clinically relevant, below-average performance
- Suitable for Research: Valuable tool for clinical studies and research
Applications
- General Clinical Evaluations: Provides relevant cognitive insights for primary care providers
- Specialised Evaluations: Useful for occupational and physical therapists as part of a comprehensive evaluation.
- Re-evaluations: Ideal for tracking individuals’ cognitive status over time
- Functional Evaluation: Helps identify cognitive challenges impacting daily activities
- Referral for Neuropsychological Testing: Determines need for more in-depth testing.
-
The WMS-5 A&NZ kits contain the necessary materials to administer and score the BCSE NU A&NZ; a separate BCSE A&NZ is not necessary for use with WMS-5 A&NZ.
-
Yes. Like the WMS-IV A&NZ, the WMS-5 A&NZ record form and response booklet contain the BCSE NU A&NZ as an optional mental status screener.
If you would like to use the BCSE A&NZ as a stand-alone screener or repeated measure, separate BCSE NU A&NZ forms are available for purchase [Product A103000448342].
Related Items
